165 related articles for article (PubMed ID: 38393001)
1. Metabolomic Profiling of Blood Plasma in Females with Hyperplasia and Endometrial Cancer.
Benabdelkamel H; Jaber MA; Akkour K; AlMalki RH; Alfadda AA; Masood A; Joy SS; Alhalal H; Alwehaibi MA; Arafah M; Alshehri E; Abdel Rahman AM
Metabolites; 2024 Feb; 14(2):. PubMed ID: 38393001
[TBL] [Abstract][Full Text] [Related]
2. Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.
Hao C; Lin S; Liu P; Liang W; Li Z; Li Y
J Obstet Gynaecol Res; 2023 Feb; 49(2):725-743. PubMed ID: 36510632
[TBL] [Abstract][Full Text] [Related]
3. Tissue-Based Proteomic Profiling in Patients with Hyperplasia and Endometrial Cancer.
Akkour K; Alanazi IO; Alfadda AA; Alhalal H; Masood A; Musambil M; Rahman AMA; Alwehaibi MA; Arafah M; Bassi A; Benabdelkamel H
Cells; 2022 Jul; 11(13):. PubMed ID: 35805203
[TBL] [Abstract][Full Text] [Related]
4. Multi-Omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer.
Yi R; Xie L; Wang X; Shen C; Chen X; Qiao L
Front Oncol; 2022; 12():861142. PubMed ID: 35574395
[TBL] [Abstract][Full Text] [Related]
5. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
6. A metabolomic signature of FIGO stage I and II endometrial cancer.
Gu M; Chen X; Sun Y; Wang L; Shu H; Qian C
Neoplasma; 2021 Nov; 68(6):1283-1291. PubMed ID: 34689564
[TBL] [Abstract][Full Text] [Related]
7. Untargeted metabolomics of saliva in pregnant women with and without gestational diabetes mellitus and healthy non-pregnant women.
Li Y; Feng Y; Yang Z; Zhou Z; Jiang D; Luo J
Front Cell Infect Microbiol; 2023; 13():1206462. PubMed ID: 37538307
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women.
Troisi J; Raffone A; Travaglino A; Belli G; Belli C; Anand S; Giugliano L; Cavallo P; Scala G; Symes S; Richards S; Adair D; Fasano A; Bottigliero V; Guida M
JAMA Netw Open; 2020 Sep; 3(9):e2018327. PubMed ID: 32986110
[TBL] [Abstract][Full Text] [Related]
9. Discovery of the potential biomarkers for early diagnosis of endometrial cancer via integrating metabolomics and transcriptomics.
Fu Y; Wang C; Wu Z; Zhang X; Liu Y; Wang X; Liu F; Chen Y; Zhang Y; Zhao H; Wang Q
Comput Biol Med; 2024 May; 173():108327. PubMed ID: 38552279
[TBL] [Abstract][Full Text] [Related]
10. Role of Nucleolin in Endometrial Precancerous Hyperplasia and Carcinogenesis: Ex Vivo and In Silico Study.
Barzilova VD; Drury J; Rogers B; Thomas E; Ahmed F; Bradfield A; Al-Lamee H; Hapangama DK
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682908
[TBL] [Abstract][Full Text] [Related]
11. Comparison of serum metabolomics in women with breast Cancer Prior to Chemotherapy and at 1 year: cardiometabolic implications.
Lyon DE; Yao Y; Garrett T; Kelly DL; Cousin L; Archer KJ
BMC Womens Health; 2023 May; 23(1):221. PubMed ID: 37138260
[TBL] [Abstract][Full Text] [Related]
12. Metabolite profiling analysis of hepatitis B virus-induced liver cirrhosis patients with minimal hepatic encephalopathy using gas chromatography-time-of-flight mass spectrometry and ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.
Huang G; Xie S; Wang M; Mao D; Huang G; Huang J; Liu X; Zhang R; Xie J; Huang LJ; Cheng C; Yao F; Zhong Y; Lin L; Yao C
Biomed Chromatogr; 2023 Jan; 37(1):e5529. PubMed ID: 36250932
[TBL] [Abstract][Full Text] [Related]
13. A Multi-Omics Approach Revealed Common Dysregulated Pathways in Type One and Type Two Endometrial Cancers.
Capaci V; Monasta L; Aloisio M; Sommella E; Salviati E; Campiglia P; Basilicata MG; Kharrat F; Licastro D; Di Lorenzo G; Romano F; Ricci G; Ura B
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003247
[TBL] [Abstract][Full Text] [Related]
14. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone.
Xu B; Chen Y; Chen X; Gan L; Zhang Y; Feng J; Yu L
Front Oncol; 2021; 11():730638. PubMed ID: 34722271
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound features of endometrial pathology in women without abnormal uterine bleeding: results from the International Endometrial Tumor Analysis study (IETA3).
Heremans R; Van Den Bosch T; Valentin L; Wynants L; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Leone FPG;
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):243-255. PubMed ID: 35385178
[TBL] [Abstract][Full Text] [Related]
18. Urine metabolomics for assessing fertility-sparing treatment efficacy in endometrial cancer: a non-invasive approach using ultra-performance liquid chromatography mass spectrometry.
Chen J; Liu J; Cao D
BMC Womens Health; 2023 Nov; 23(1):583. PubMed ID: 37940929
[TBL] [Abstract][Full Text] [Related]
19. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]